Impact of Hospital Case Volume on Uterine Sarcoma Prognosis: SARCUT Study Subanalysis.

Mikel GorostidiYusuf YildirimRonalds MacuksRosanna MancariPatriciu Achimas-CadariuEduardo IbañezGiacomo CorradoArnoldas BartuseviciusOlena SukhinaIgnacio Zapardielnull null

Published in: Annals of surgical oncology (2023)

The prognosis for patients with uterine sarcoma is directly related to complete tumor cytoreduction, histologic type, and FIGO stage, with significant differences between low and high case-volume centers. Patients with uterine sarcomas should be centralized in HighCV centers to improve their oncologic outcomes.

Keyphrases

healthcare
prostate cancer
radical prostatectomy
type diabetes
adipose tissue
skeletal muscle
insulin resistance
weight loss